Education
About Us
Working with TipRanks
Follow Us
HLS Therapeutics Inc (TSE:HLS)
TSX:HLS
Earnings Data
Report Date
Mar 12, 2026Before Open (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.04Last Year’s EPS
-0.14Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call reflects a mixed performance, with strong adjusted EBITDA growth and a solid financial position, but challenges in revenue growth and competitive pressures in the Clozaril business. While there are significant achievements, the revenue decline and lower-than-expected growth in certain areas indicate a balanced sentiment.Company Guidance
Strong Adjusted EBITDA Growth
Adjusted EBITDA reached $4.9 million in Q3, up 19% year-over-year, and $13.9 million year-to-date, up 25% compared to the same period in 2024.
Vascepa Prescription Growth
Vascepa prescriptions grew 24% year-to-date, with Q3 being its most profitable since launch.
Debt Reduction and Financial Strengthening
Significant debt reduction, with net debt at $43.5 million, down from $50 million at the end of 2024, and a new favorable credit agreement.
Bempedoic Acid Launch Preparations
Preparations for the Q2 2026 launch of bempedoic acid, with potential to address a large Canadian market.
TSE:HLS Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TSE:HLS Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 13, 2025 | C$5.14 | C$4.75 | -7.59% |
Aug 14, 2025 | C$5.13 | C$5.09 | -0.78% |
May 08, 2025 | C$4.49 | C$4.60 | +2.45% |
Mar 13, 2025 | C$4.01 | C$3.96 | -1.25% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does HLS Therapeutics Inc (TSE:HLS) report earnings?
HLS Therapeutics Inc (TSE:HLS) is schdueled to report earning on Mar 12, 2026, Before Open (Confirmed).
What is HLS Therapeutics Inc (TSE:HLS) earnings time?
HLS Therapeutics Inc (TSE:HLS) earnings time is at Mar 12, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TSE:HLS EPS forecast?
TSE:HLS EPS forecast for the fiscal quarter 2025 (Q4) is -0.04.